While exhibiting its offering in self-administration devices at the CPhI Worldwide event in Frankfurt last week, West told us how patient convenience drives design and development.
West Pharmaceutical Services’ operating income fell by 33 per cent in Q2 but the company reported that demand for some of its drug delivery technology is strong.
With Asia increasingly becoming the destination of choice for
manufacturers and the domestic market blossoming, a major
components manufacturer has singled out its Singapore facility for
a multi-million dollar expansion.
West Pharmaceutical Services is to sell a substantial part of its
drug delivery business to a newly formed company in return for $7.1
million (€5.3m) in cash and a 14 per cent stake in the new firm.